Literature DB >> 11429703

The CpG island of the novel tumor suppressor gene RASSF1A is intensely methylated in primary small cell lung carcinomas.

R Dammann1, T Takahashi, G P Pfeifer.   

Abstract

Loss of heterozygosity at 3p21.3 occurs in more than 90% of small cell lung carcinomas (SCLCs). The Ras association domain family 1 (RASSF1) gene cloned from the lung tumor suppressor locus 3p21.3 consists of two major alternative transcripts, RASSF1A and RASSF1C. Epigenetic inactivation of isoform A (RASSF1A) was observed in 40% of primary non-small cell lung carcinomas and in several tumor cell lines. Transfection of RASSF1A suppressed the growth of lung cancer cells in vitro and in nude mice. Here we have analysed the methylation status of the CpG island promoters of RASSF1A and RASSF1C in primary SCLCs. In 22 of 28 SCLCs (=79%) the promoter of RASSF1A was highly methylated at all CpG sites analysed. None of the SCLCs showed evidence for methylation of the CpG island of RASSF1C. The results suggest that hypermethylation of the CpG island promoter of the RASSF1A gene is associated with SCLC pathogenesis.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11429703     DOI: 10.1038/sj.onc.1204469

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  34 in total

1.  DNA methylation biomarkers for lung cancer.

Authors:  Tibor A Rauch; Zunde Wang; Xiwei Wu; Kemp H Kernstine; Arthur D Riggs; Gerd P Pfeifer
Journal:  Tumour Biol       Date:  2011-12-06

2.  RASSF1A promoter methylation and Kras2 mutations in non small cell lung cancer.

Authors:  Jie Li; Zhongqiu Zhang; Zunyan Dai; Anthony P Popkie; Christoph Plass; Carl Morrison; Yian Wang; Ming You
Journal:  Neoplasia       Date:  2003 Jul-Aug       Impact factor: 5.715

Review 3.  Epigenetics of lung cancer.

Authors:  Scott M Langevin; Robert A Kratzke; Karl T Kelsey
Journal:  Transl Res       Date:  2014-03-12       Impact factor: 7.012

4.  Epigenetic aberrant methylation of tumor suppressor genes in small cell lung cancer.

Authors:  Shuai Wang; Zhou Wang
Journal:  J Thorac Dis       Date:  2013-08       Impact factor: 2.895

5.  RASSF1A Deficiency Enhances RAS-Driven Lung Tumorigenesis.

Authors:  M Lee Schmidt; Katharine R Hobbing; Howard Donninger; Geoffrey J Clark
Journal:  Cancer Res       Date:  2018-05-07       Impact factor: 12.701

6.  Safeguarding genome stability: RASSF1A tumor suppressor regulates BRCA2 at stalled forks.

Authors:  Dafni Eleftheria Pefani; Eric O'Neill
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

Review 7.  Lung cancer. 9: Molecular biology of lung cancer: clinical implications.

Authors:  K M Fong; Y Sekido; A F Gazdar; J D Minna
Journal:  Thorax       Date:  2003-10       Impact factor: 9.139

8.  The DNA methylation landscape of small cell lung cancer suggests a differentiation defect of neuroendocrine cells.

Authors:  S Kalari; M Jung; K H Kernstine; T Takahashi; G P Pfeifer
Journal:  Oncogene       Date:  2012-08-20       Impact factor: 9.867

9.  Ras-association domain family 1C protein promotes breast cancer cell migration and attenuates apoptosis.

Authors:  Mark E Reeves; Scott W Baldwin; Melissa L Baldwin; Shin-Tai Chen; Jeremy M Moretz; Robert J Aragon; Xinmin Li; Donna D Strong; Subburaman Mohan; Yousef G Amaar
Journal:  BMC Cancer       Date:  2010-10-18       Impact factor: 4.430

Review 10.  DNA methylation patterns in lung carcinomas.

Authors:  Gerd P Pfeifer; Tibor A Rauch
Journal:  Semin Cancer Biol       Date:  2009-02-20       Impact factor: 15.707

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.